Cargando…

Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience

BACKGROUND: Clinicopathological features and surgical outcomes of patients with fibrolamellar hepatocellular carcinoma (FL-HCC) are underreported. The aim of this study is to describe clinical characteristics and surgical outcomes for patients with this rare tumor to raise awareness among clinicians...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemekhova, Anastasia, Hornuss, Daniel, Polychronidis, Georgios, Mayer, Philipp, Rupp, Christian, Longerich, Thomas, Weiss, Karl-Heinz, Büchler, Markus, Mehrabi, Arianeb, Hoffmann, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218513/ https://www.ncbi.nlm.nih.gov/pubmed/32397993 http://dx.doi.org/10.1186/s12957-020-01855-2

Ejemplares similares

Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database
por: Polychronidis, Georgios, et al.
Publicado: (2022)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
por: Palm, Viktoria, et al.
Publicado: (2018)

A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects
por: Polychronidis, Georgios, et al.
Publicado: (2022)

Evaluation of the impact of Tacrolimus-based immunosuppression on Heidelberg liver transplant cohort (HDTACRO): Study protocol for an investigator initiated, non-interventional prospective study
por: Khajeh, Elias, et al.
Publicado: (2020)

Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular Carcinoma
por: Lozanovski, Vladimir J., et al.
Publicado: (2019)

Long term follow up after resection emphasizes the role of surgery in Primary Hepatic Epithelioid Hemangioendothelioma
por: Mehrabi, Arianeb, et al.
Publicado: (2016)

Pringle Maneuver in Extended Liver Resection: A propensity score analysis
por: Al-Saeedi, Mohammed, et al.
Publicado: (2020)

Incidence trends and survival prediction of hepatoblastoma in children: a population-based study
por: Feng, Jincheng, et al.
Publicado: (2019)

Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features
por: Murtha-Lemekhova, Anastasia, et al.
Publicado: (2021)

Establishing a Standardized Measure of Quality in Pediatric Liver Surgery: Definition and Validation of Textbook Outcome With Associated Predictors
por: Fuchs, Juri, et al.
Publicado: (2021)

Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis
por: Billeter, Adrian T., et al.
Publicado: (2020)

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
por: Wehling, Cyrill, et al.
Publicado: (2021)

HSP70–eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma
por: Wang, Meng, et al.
Publicado: (2020)

Preoperative Thrombocytopenia May Predict Poor Surgical Outcome after Extended Hepatectomy
por: Golriz, Mohammad, et al.
Publicado: (2018)

Nutritional risk in major abdominal surgery: NURIMAS Liver (DRKS00010923) – protocol of a prospective observational trial to evaluate the prognostic value of different nutritional scores in hepatic surgery
por: Probst, Pascal, et al.
Publicado: (2017)

Surgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
por: Minutolo, Vincenzo, et al.
Publicado: (2013)

Markers of liver regeneration—the role of growth factors and cytokines: a systematic review
por: Hoffmann, Katrin, et al.
Publicado: (2020)

Mixed fibrolamellar hepatocellular carcinoma
por: Limaiem, Faten, et al.
Publicado: (2021)

Evaluation of the role of transhepatic flow in postoperative outcomes following major hepatectomy (THEFLOW): study protocol for a single-centre, non-interventional cohort study
por: Golriz, Mohammad, et al.
Publicado: (2019)

Correction: Wang, M., et al. HSP70–eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma. Cancers 2020, 12, 2262
por: Wang, Meng, et al.
Publicado: (2020)

Prognostic Value of Red Blood Cell Distribution Width (RDW) in the Recurrence of Hepatocellular Carcinoma Following Curative Resection
por: Golriz, Mohammad, et al.
Publicado: (2022)

Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses
por: Fuchs, Juri, et al.
Publicado: (2022)

Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma
por: G. Peacock, Justin, et al.
Publicado: (2013)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
por: Villa, Nicolas A., et al.
Publicado: (2015)

Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
por: Vogeler, Marie, et al.
Publicado: (2020)

Routine Postoperative Antibiotic Prophylaxis Offers No Benefit after Hepatectomy—A Systematic Review and Meta-Analysis
por: Murtha-Lemekhova, Anastasia, et al.
Publicado: (2022)

Mitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas
por: Vivekanandan, Perumal, et al.
Publicado: (2010)

Synchronous Fibrolamellar Hepatocellular Carcinoma and Auricular Myxoma
por: González-Cantú, Yessica M., et al.
Publicado: (2015)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015)

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)

Spontaneous Rupture of Fibrolamellar Variant Hepatocellular Carcinoma
por: Polavarapu, Abhishek D., et al.
Publicado: (2019)

Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022)

Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma
por: Mohr, Isabelle, et al.
Publicado: (2022)

Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection
por: Mafeld, Sebastian, et al.
Publicado: (2018)

Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma
por: Alsina, Angel E., et al.
Publicado: (2016)

Non coding RNA analysis in fibrolamellar hepatocellular carcinoma
por: Farber, Benjamin A., et al.
Publicado: (2017)

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
por: Thakral, Nimish, et al.
Publicado: (2020)

Fibrolamellar Variant of Hepatocellular Carcinoma in a Young Female
por: Walsh, Kevin, et al.
Publicado: (2021)

Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event
por: Abdelhamed, Walaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tmschf6kmvri7h5dbo1l03g42g